Quantumscape Corp (QS) Stock Analysis
Verdict: AVOID
Zero-revenue solid-state battery specs face heavy cash burn and ongoing insider selling, leaving commercialization risk uncompensated.
Investment score: 32/100
Analysis as of
Is Quantumscape Corp stock worth reviewing? The TradeMates thesis
The model assigns an Investment Score of 32/100 and an AVOID verdict due to uncompensated commercialization risk, zero current revenue, -$278.8M annual FCF burn, and persistent insider selling.
7-factor investment score
- Valuation: 25/100 (weight 20%)
- Financial Health: 45/100 (weight 15%)
- Technical Momentum: 20/100 (weight 15%)
- Earnings Quality: 60/100 (weight 15%)
- Insider Sentiment: 10/100 (weight 10%)
- Analyst Consensus: 30/100 (weight 10%)
- Risk-Adjusted Return: 25/100 (weight 15%)
Quantumscape Corp opportunities and risks
What speaks for QS
- Liquidity runway extends into late 2028
What speaks against QS
- Anchor customer commitment reduction and royalty capping
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| QS | n/a | 0.0x | n/a | 0.0% | 0.0% | -10.4% |
| LEA | 11.3x | 0.3x | 5.8x | 7.0% | 2.3% | 14.2% |
| GNTX | 11.2x | 1.7x | 13.3x | 35.0% | 15.5% | 11.2% |
| DORM | 17.0x | 1.7x | 10.7x | 42.1% | 10.2% | 5.8% |
| DAN | n/a | n/a | 8.8x | -1.7% | 47.4% | 4.3% |
| VC | 15.8x | 0.6x | 5.5x | 12.8% | 4.0% | 6.8% |
| Peer median | 11.3x | 0.6x | 8.8x | 12.8% | 10.2% | 6.8% |
Frequently asked questions about Quantumscape Corp (QS)
Is QS stock a good investment?
The TradeMates model rates Quantumscape Corp as AVOID with an investment score of 32/100. The model assigns an Investment Score of 32/100 and an AVOID verdict due to uncompensated commercialization risk, zero current revenue, -$278.8M annual FCF burn, and persistent insider selling. This is algorithmic model output, not personal investment advice.
Is QS stock a buy?
The TradeMates model verdict for QS is AVOID with an investment score of 32/100. Treat this as a model signal to review, not a personal buy recommendation.